Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Draft Provider-Administered Drug Policies .

Aldurazyme

Benlysta

Cerezyme

Elaprase

Emend, Fosaprepitant, Focinvez

 

 

Fabrazyme

Aralast NP; Glassia; Prolastin-C; Zemaira

Lumizyme

Lupron Depot, Lupron Depot-Ped, Eligard, Fensolvi, Lutrate Depot, Camcevi,  Leuprolide Acetate Depot 

Naglazyme

Elelyso

Rituxan, Truxima, Ruxience, Riabni

Soliris, Bkemv, Epysqli

Stelara, Wezlana, Selarsdi, Pyzchiva, Otulfi, Imuldosa, Yesintek, Steqeyma, Ustekinumab-aekn

Velcade, Boruzu, Bortezomib

VPRIV

Vimizim

Neulasta, Fulphila, Udenyca, Ziextenzo, Nyvepria; Fylnetra, Stimufend, Rolvedon, Ryzneuta, Pegfilgrastim-fpgk

Kanuma

Exondys 51